Rodney Hoff

Clinical Professor, Global Health (Primary department)
Clinical Professor, Env. and Occ. Health Sciences

Rod Hoff recently joined the UW SPH where he is working with faculty to expand the School's research programs on emerging infectious diseases.

Prior to joining the UW SPH Rod served for 6 years as the Executive Director of the Regional Emerging Diseases Intervention (REDI) Center in Singapore, which had a mission to enhance the Asia Pacific Region capacity to monitor, detect and respond to emerging disease threats. The Center sponsored regional research projects on avian and seasonal influenza, dengue, chikungunya, acute respiratory diseases, and hand foot and mouth disease. The Center also conducted training workshops on prevention of hospital acquired infections, laboratory diagnosis of avian and seasonal influenza, laboratory biosafety, field epidemiology, outbreak investigation and response and monitoring and evaluation of HIV and TB treatment programs. These activities resulted in comprehensive reports on Strengthening Health Security and Bio-Preparedness in Southeast Asia and a Guide to Clinical Management and Public Health Response for Hand, Foot and Month Diseases (HFMD).

Prior his Singapore experience, Rod worked for 16 years at the Division of AIDS at the National Institute of Allergy and Infectious Diseases at NIH where he coordinated development of the HIVNET and HPTN multi-center clinical trial networks for evaluating vaccines and other preventive interventions for HIV and the Comprehensive International Program for Research on AIDS (CIPRA) that supported HIV/AIDS research projects in 24 countries. He also chaired the Scientific Review Committee for HIV Vaccine and Prevention Research at NIAID. Rod retired from NIH in 2006.

Rod received his Doctor of Science Degree from Harvard University School of Public Health in 1974 and has held faculty positions at Harvard School of Public Health from 1975-1985 and at Tufts Medical School from 1986-90. He served with the US Peace Corps in Thailand from 1965-67 and as a Medical Service Officer in the US Army from 1968 to 1971. From 1974-1979 he headed the Harvard/Wellcome Bahia Project in Brazil where he conducted research on Chagas disease, schistosomiasis, and leishmaniais. While at Massachusetts State Laboratory from 1985-1990 he implemented state-wide newborn screening programs for congenital toxoplasmosis and sickle cell disease and designed and initiated a multi-state study of HIV seroprevalence in childbearing women by testing anonymous blood samples from newborns.

Contact Information

Seattle, WA -
Tel: 206-612-2236

Research Interests

  • Epidemiology and control of emerging Infectious Diseases,
    Development of global capacity to prevent and control emerging infectious diseases,
    Integrated human and animal health (One Health) approaches for prevention and control of zoonotic diseases,
    Development of laboratory capacity of diagnosis of emerging infectious diseases.

Teaching interests

Epidemiology and control of emerging infectious diseases,
Impact of climate and environmental change on the emergence and geographic distribution of infectious diseases.

Education

DSc, Tropical Public Health, Harvard University, 1974
MS, Tropical Public Health, Harvard University, 1972
MPH, Parasitology, University of North Carolina (Chapel Hill), 1968
BS, Biology, University of Wisconsin, 1965

Projects

USAID EPT-2 Supporting National One Health Platforms and Investing in the One Health Work Force (Grant submitted)
WHO Collaborating Center for Preparedness for Mass Gatherings (Proposal submitted)
Identification and Resolution of Barriers to Establishing Laboratory Testing Capacity for Emerging Diseases in Developing Countries (In development)
Selected Publications

Hoff R, Berardi VP, Weiblen BJ, Mahoney Trout L, Mitchell ML, and Grady GF, 1988. HIV seroprevalence in childbearing women: estimation by testing newborn blood samples collected on absorbent paper. NEJM, 318:525 530

Gwinn M, Pappaioanou M, George JR, Hannon WH, Wasser SC, Redus MA, Hoff R, Grady GF, Willoughby A, Novello AC, Peterson LR, Dondero TJ, Curran JW, 1991. Prevalence of HIV infection in childbearing women in the United States: Surveillance using newborn blood samples. JAMA 265:1704-1708

Weiblen BJ, Lee FK, Cooper ER, Landesman SH, McIntosh K, Harris JS, Neshaim S, Mendez H, Pelton S, Nahmias AJ, Hoff R, 1990. Early diagnosis of HIV infection in infants by detection of IgA antibodies. Lancet 335:988-990

Bremer JW, Lew JF, Cooper E, Hillyer GV, Pitt J, Handelsman E, Brambilla D, Moye J, Hoff, R. 1996. Diagnosis of infection with human immunodeficiency virus type I by a DNA polymerase chain reaction assay among infants enrolled in the women and Infants' Transmission Study. J. Ped. 129:198-207

Cooper ER, Charuat MS, Mofenson l, Hanson IC, Pitt J, Diaz C, Hayani K, Hadelsman E., Sermeriglio V, Hoff R, and Blattmer W. 2002. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission. JAIDS. 29:484-494

Reed Z, Hoff R and Piedangel JM). 2011. Strengthening Health Security and Biopreparedness in Southeast Asia: Opportunities for Engagement. A Report Prepared for the Defense Threat Reduction Agency of the US Department of Defense 107 pp

REDI Center and WHO Western Pacific Region. 2011 A Guide to Clinical Management and Public Health Response for Hand Foot and Mouth Disease (HFMD). WHO Press, World Health Organization 63pp

Review date: 
2/23/2016